Ann: Admedus Receives FDA Clearance for CardioCel 3D, page-59

Bought back in at the open to trigger a short sell-off to buy lower and as always we can count on the sellers - they never disappoint.

Re-entered for 2 reasons:

1. Finally they should reach profitability soon

2. MEERKAT is buying and positive - Hallelujahhhhhhhh

Don't expect much of the vax as a year or so ago the Prof. used the "encouraging " word which means " not a failure but not a success either ".

But CC and all its applications should turn AHZ in a profitable company and if the Prof, against my prediction, created a breakthrough vax I won't mind it at all.

GLTA